Literature DB >> 10684928

Effects of RNA secondary structure on cellular antisense activity.

T A Vickers1, J R Wyatt, S M Freier.   

Abstract

The secondary and tertiary structures of a mRNA are known to effect hybridization efficiency and potency of antisense oligonucleotides in vitro. Additional factors including oligonucleotide stability and cellular uptake are also thought to contribute to antisense potency in vivo. Each of these factors can be affected by the sequence of the oligonucleotide. Although mRNA structure is presumed to be a critical determinant of antisense activity in cells, to date little direct experimental evidence has addressed the significance of structure. In order to determine the importance of mRNA structure on antisense activity, oligonucleotide target sites were cloned into a luciferase reporter gene along with adjoining sequence to form known structures. This allowed us to study the effect of target secondary structure on oligonucleotide binding in the cellular environment without changing the sequence of the oligonucleotide. Our results show that structure does play a significant role in determining oligonucleotide efficacy in vivo. We also show that potency of oligonucleotides can be improved by altering chemistry to increase affinity for the mRNA target even in a region that is highly structured.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684928      PMCID: PMC111043          DOI: 10.1093/nar/28.6.1340

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  50 in total

1.  Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H.

Authors:  H Inoue; Y Hayase; S Iwai; E Ohtsuka
Journal:  FEBS Lett       Date:  1987-05-11       Impact factor: 4.124

Review 2.  On finding all suboptimal foldings of an RNA molecule.

Authors:  M Zuker
Journal:  Science       Date:  1989-04-07       Impact factor: 47.728

3.  Single-nucleotide polymorphisms can cause different structural folds of mRNA.

Authors:  L X Shen; J P Basilion; V P Stanton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 4.  Antimessenger oligodeoxyribonucleotides: an alternative to antisense RNA for artificial regulation of gene expression--a review.

Authors:  J J Toulmé; C Hélène
Journal:  Gene       Date:  1988-12-10       Impact factor: 3.688

5.  The binding of complementary oligoribonucleotides to yeast initiator Transfer RNA.

Authors:  S M Freier; I Tinoco
Journal:  Biochemistry       Date:  1975-07-29       Impact factor: 3.162

6.  Number and distribution of methylphosphonate linkages in oligodeoxynucleotides affect exo- and endonuclease sensitivity and ability to form RNase H substrates.

Authors:  R S Quartin; C L Brakel; J G Wetmur
Journal:  Nucleic Acids Res       Date:  1989-09-25       Impact factor: 16.971

7.  Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides.

Authors:  J Goodchild; S Agrawal; M P Civeira; P S Sarin; D Sun; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Evaluation of N-ras oncogene anti-sense, sense and nonsense sequence methylphosphonate oligonucleotide analogues.

Authors:  D M Tidd; P Hawley; H M Warenius; I Gibson
Journal:  Anticancer Drug Des       Date:  1988-08

9.  Physicochemical properties of phosphorothioate oligodeoxynucleotides.

Authors:  C A Stein; C Subasinghe; K Shinozuka; J S Cohen
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

10.  Partial protection of oncogene, anti-sense oligodeoxynucleotides against serum nuclease degradation using terminal methylphosphonate groups.

Authors:  D M Tidd; H M Warenius
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

View more
  58 in total

1.  Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes.

Authors:  M Amarzguioui; G Brede; E Babaie; M Grotli; B Sproat; H Prydz
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

2.  5'-bis-pyrenylated oligonucleotides displaying excimer fluorescence provide sensitive probes of RNA sequence and structure.

Authors:  E Kostenko; M Dobrikov; D Pyshnyi; V Petyuk; N Komarova; V Vlassov; M Zenkova
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

3.  Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo.

Authors:  M Sohail; H Hochegger; A Klotzbücher; R L Guellec; T Hunt; E M Southern
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

4.  Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.

Authors:  Peter A C 't Hoen; Ruud Out; Jan N M Commandeur; Nico P E Vermeulen; F H D van Batenburg; Muthiah Manoharan; Theo J C van Berkel; Erik A L Biessen; Martin K Bijsterbosch
Journal:  RNA       Date:  2002-12       Impact factor: 4.942

5.  LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1.

Authors:  Fabien Darfeuille; Jens Bo Hansen; Henrik Orum; Carmelo Di Primo; Jean-Jacques Toulmé
Journal:  Nucleic Acids Res       Date:  2004-06-04       Impact factor: 16.971

6.  Identification of genes involved in liver cancer cell growth using an antisense library of phage genomic DNA.

Authors:  Yun Han Lee; Young Ho Kim; Jong Gu Park
Journal:  Cancer Res Treat       Date:  2004-08-31       Impact factor: 4.679

Review 7.  Small molecule targeting of RNA structures in neurological disorders.

Authors:  Alicia J Angelbello; Jonathan L Chen; Matthew D Disney
Journal:  Ann N Y Acad Sci       Date:  2019-04-09       Impact factor: 5.691

8.  siRNAs target sites selection of ezrin and the influence of RNA interference on ezrin expression and biological characters of osteosarcoma cells.

Authors:  XiFu Shang; YaoFei Wang; QiChun Zhao; KeRong Wu; Xu Li; XiaoFeng Ji; Rui He; WenZhi Zhang
Journal:  Mol Cell Biochem       Date:  2012-05       Impact factor: 3.396

Review 9.  Targeting RNA in mammalian systems with small molecules.

Authors:  Anita Donlic; Amanda E Hargrove
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-05-03       Impact factor: 9.957

10.  Design of phosphorodiamidate morpholino oligomers (PMOs) for the induction of exon skipping of the human DMD gene.

Authors:  Linda J Popplewell; Capucine Trollet; George Dickson; Ian R Graham
Journal:  Mol Ther       Date:  2009-01-13       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.